Companies Cryptocurrencies
Theratechnologies Inc
Theratechnologies Inc
Exchange: NasdaqCM
IPO Date: 21/12/1993
CEO: Mr. Luc Tanguay
Drug Manufacturers General Specialty & Generic Healthcare 🔗
  • THTX
  • 2.17
  • 206413872
    market cap
  • 0
If you bought

shares of Theratechnologies Inc (THTX) on
You would have made
Old Price $12 Current Price $12

Theratechnologies, Inc. is a pharmaceutical company. The company is headquartered in Montreal, Quebec and currently employs 32 full-time employees. The firm addresses medical needs to promote healthy living for human immunodeficiency virus (HIV) patients. Its products include EGRIFTA and Ibalizumab. EGRIFTA (tesamorelin for injection) refers to tesamorelin and it is indicated for the reduction of excess abdominal fat in HIV infected patients with lipodystrophy. EGRIFTA is indicated for the treatment of excess visceral adipose tissue (VAT), as assessed by waist circumference of approximately 100 centimeters for males and approximately 90 centimeters for females. Ibalizumab is a cluster difference 4 (CD4)-directed HIV entryinhibitor, which focuses on treating multidrug resistant HIV-1 infection (MDR HIV-1). Ibalizumab binds to the second extracellular domain of the CD4 receptor. Ibalizumab has completed the Phase III trial. EGRIFTA is available in Canada and in the United States. The firm distributes EGRIFTA in the United States through RxC Acquisition.

Address: 2015 Peel St 5th Floor MONTREAL QUEBEC

Stay updated.